AMERIPRISE FINANCIAL INC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$824,457
-$301,727 QoQ
Shares Held
142,148
-0.9% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 55.30644117398767.ToString("F0")%
None 44.69355882601233.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. XERS ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,014,966 | $270,402,187 | |
| 2 | ZTS |
Zoetis Inc.
|
1,610,634 | $190,393,043 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
512,033 | $67,455,225 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
91,225 | $54,094,599 | |
| 5 | ALKS |
Alkermes plc.
|
741,141 | $26,206,745 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,865,201 | $23,184,446 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
270,262 | $20,783,147 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
269,945 | $20,475,327 |
All Filings in XERS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $824,457 | 142,148 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,126,184 | 143,463 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,254,927 | 154,168 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $695,959 | 149,028 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $922,879 | 168,102 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $711,638 | 209,923 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $618,703 | 217,089 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $494,788 | 219,906 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,106,651 | 953,236 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,222,284 | 520,121 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,093,564 | 587,938 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,552,370 | 592,508 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $927,872 | 569,247 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $758,189 | 570,067 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $889,304 | 570,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $636,780 | 413,494 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,069,475 | 417,764 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $148,260 | 50,601 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||